In Novaritis Pharmaceuticals Corp. v. Accord Healthcare, Inc., [2021-1070](January 3, 2021) the Federal Circuit affirmed the district court’s determination that U.S. Patent No. 9,187,405 on a treatment for relapsing remitting multiple sclerosis (“RRMS”), is not invalid and that HEC’s Abbreviated … Continue reading Silence is not only Golden, it is a Written Description, if the Skilled Artisan Would Understand it that Way